Starsource Multi

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE320M01019
  • NSEID:
  • BSEID: 506365
INR
116.50
0.00 (0.00%)
BSENSE

Apr 17

BSE+NSE Vol: 148

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 674875,
    "name": "Starsource Multi",
    "stock_name": "Starsource Multi",
    "full_name": "Starsource Multitrade Ltd",
    "name_url": "stocks-analysis/starsource-multi",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "116.50",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "116.50",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506365,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE320M01019",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": "148 ",
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/starsource-multi-674875-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Starsource Multitrade Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-starsource-multitrade-ltd-3831848",
        "imagepath": "",
        "date": "2026-02-10 23:17:51",
        "description": "The next results date for Starsource Multitrade Ltd is scheduled for 12 February 2026...."
      }
    ],
    "total": 54,
    "sid": "674875",
    "stock_news_url": "https://www.marketsmojo.com/news/starsource-multitrade-674875"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "15-Apr-2026",
      "details": "Non Applicability of Annual Secretarial Compliance Report for the year ended on March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "15-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Star Source Multi Trade Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1942PLC003556</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.01</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Aditya Agarwal <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: chemopharmalaboratorieslimited@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Utsav Trivedi <br/> Designation: Chief Financial Officer <br/> EmailId: chemopharmalaboratorieslimited@gmai.com</div> </div> <div> <br/> Date: 15/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Apr-2026",
      "details": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018-March-2026 Quarter",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Compliances-Reg.24(A)-Annual Secretarial Compliance

15-Apr-2026 | Source : BSE

Non Applicability of Annual Secretarial Compliance Report for the year ended on March 31 2026.

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

15-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyStar Source Multi Trade Ltd
2CIN NO.L99999MH1942PLC003556
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.01
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Aditya Agarwal
Designation: Company Secretary and Compliance Officer
EmailId: chemopharmalaboratorieslimited@gmail.com
Name of the Chief Financial Officer: Utsav Trivedi
Designation: Chief Financial Officer
EmailId: chemopharmalaboratorieslimited@gmai.com

Date: 15/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Apr-2026 | Source : BSE

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018-March-2026 Quarter

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available